New York (1)

Breast Cancer (1)

Cyclophosphamide (1)

Doxorubicin (1)

High Risk (1)

Positive Nodes (1)

Completed (1)

phase 3 (1)

National Cancer Institute (NCI) (1)

Cancer and Leukemia Group B (1)

ciprofloxacin (1)

cyclophosphamide (1)

doxorubicin (1)

g-csf (1)

tamoxifen (1)

drug (1)

NIH (1)

Interventional (1)

doxorubicin

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Aug 24, 2017